CommercialCoverageMedium impact
06.02.01m, Lyme Disease: Diagnosis and Intravenous (IV) Antibiotic Therapy
Independence Blue Cross·Family Medicine, Internal Medicine, Infectious Disease +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Updated policy for Lyme Disease diagnosis and intravenous antibiotic therapy will take effect April 1, 2026. This policy may affect coverage criteria, prior authorization requirements, or billing guidelines for IV antibiotic treatments related to Lyme disease diagnosis.
Action Required
Before April 1, 2026: Review updated Lyme Disease policy 06.02.01m at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation needs for IV antibiotic therapy. Update billing workflows and staff training accordingly based on the full policy content.